Shuli Yang

924 citations

34 papers · 616 indexed · h-index 14

Impact in

Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Obstetrics and Gynecology top 10%

Papers in ⓘ

Molecular Biology 12
- Circular RNAs in diseases 5
- RNA modifications and cancer 2
Cancer Research 12
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Cancer, Lipids, and Metabolism 2

Co-authors: Ruixin Lin (14 shared papers)Lihui Si (8 shared papers)Ruiqi Yang (2 shared papers)Yan Jia (6 shared papers)Jiacheng Wu (4 shared papers)Zongbing You (1 shared paper)Keshab R. Parajuli (1 shared paper)Shuang Liu (1 shared paper)
Journals: Bioscience Reports (3 papers)Frontiers in Endocrinology (2 papers)Microbial Pathogenesis (1 paper)European Journal of Medicinal Chemistry (1 paper)Journal of Microbiology Immunology and Infection (1 paper)
Partner nations: China Taiwan United States

In The Last Decade

Shuli Yang

32 papers receiving 601 citations

Peers

Countries citing papers authored by Shuli Yang

Since Specialization

Citations

This map shows the geographic impact of Shuli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Yang more than expected).

Fields of papers citing papers by Shuli Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Yang. The network helps show where Shuli Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Shuli Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuli Yang Line = papers co-authored together Shuli Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition Oncogene ·Q Zhang, Shuang Liu, Keshab R. Parajuli, W Zhang, K Zhang, Zongqi Mo, J Liu, Z Chen, Shuli Yang, A R Wang, Leann Myers, Zongbing You	2016	157
2	CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer Cancer Letters ·Wanqiong Yuan, Baocai Liu, Xiaolin Wang, Ting Li, Hui Xue, Xiaoning Mo, Shuli Yang, Shigang Ding, Wenling Han	2016	55
3	Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway Bioscience Reports ·Lihui Si, Ruiqi Yang, Ruixin Lin, Shuli Yang	2018	52
4	Kaempferol exerts anti-proliferative effects on human ovarian cancer cells by inducing apoptosis, G0/G1 cell cycle arrest and modulation of MEK/ERK and STAT3 pathways. PubMed ·Shuli Yang, Lihui Si, Yan Jia, Wenwen Jian, Qing Yu, Min Wang, Ruixin Lin	2020	37
5	Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs Seminars in Cancer Biology ·Ruixin Lin, Shuli Yang, Yan Jia, Jiacheng Wu, Zhuang Xu, Hong Zhang	2021	33
6	Cuproptosis: emerging biomarkers and potential therapeutics in cancers Frontiers in Oncology ·Min Wang, Lianwen Zheng, Shuai Ma, Ruixin Lin, Jiahui Li, Shuli Yang	2023	25
7	Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma Bioscience Reports ·Guofeng Zhang, Ling Qiu, Shuli Yang, Jiacheng Wu, Tongjun Liu	2020	25
8	Leiomyomatosis peritonealis disseminata associated with endometriosis: A case report and review of the literature Oncology Letters ·Rulin Yang, Tianmin Xu, Yingwei Fu, SONGHUA CUI, Shuli Yang, Manhua Cui	2014	23
9	Lactobacillus bulgaricus improves antioxidant capacity of black garlic in the prevention of gestational diabetes mellitus: a randomized control trial Bioscience Reports ·Lihui Si, Ruixin Lin, Yan Jia, Wenwen Jian, Qing Yu, Min Wang, Shuli Yang	2019	22
10	Autophagy Regulation by the Nuclear Factor κB Signal Axis in Acute Pancreatitis Pancreas ·Shuli Yang, Men Bing, Fengmei Chen, Ying Sun, Huang Chen, Weichang Chen	2011	20
11	lncRNA HEIH accelerates cell proliferation and inhibits cell senescence by targeting miR-3619-5p/CTTNBP2 axis in ovarian cancer Menopause The Journal of The North American Menopause Society ·Lihui Si, Jun Chen, Shuli Yang, Ziwei Liu, Yuying Chen, Minhua Peng, Yan Jia	2020	17
12	Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial Journal of Diabetes Research ·Shuli Yang, Ruixin Lin, Lihui Si, Zhuo Li, Wenwen Jian, Qing Yu, Yan Jia	2019	16
13	Mefloquine targets β -catenin pathway and thus can play a role in the treatment of liver cancer Microbial Pathogenesis ·Yuhui Li, Shuli Yang, Guofeng Zhang, Jiacheng Wu, Lulu Gong, Mingzhong, Ruixin Lin	2018	14
14	LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9 Digestive Diseases and Sciences ·Ruixin Lin, Guo-Feng Zhan, Jiacheng Wu, Fang He, Shuli Yang	2021	13
15	Biogenesis and function of exosome lncRNAs and their role in female pathological pregnancy Frontiers in Endocrinology ·Min Wang, Lianwen Zheng, Shuai Ma, Ruixin Lin, Jiahui Li, Shuli Yang	2023	13
16	Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71 Nature Communications ·Kuan-Ying A. Huang, Daming Zhou, Elizabeth E. Fry, Abhay Kotecha, Peng-Nien Huang, Shuli Yang, Kuo‐Chien Tsao, Yhu‐Chering Huang, Tzou‐Yien Lin, Jingshan Ren, David I. Stuart	2020	13
17	MicroRNA-375 inhibits the growth, drug sensitivity and metastasis of human ovarian cancer cells by targeting PAX2. PubMed ·Shuli Yang, Ruiqi Yang, Ruixin Lin, Lihui Si	2020	12
18	Thiophenol-formaldehyde triazole causes apoptosis induction in ovary cancer cells and prevents tumor growth formation in mice model European Journal of Medicinal Chemistry ·Yan Jia, Lihui Si, Ruixin Lin, Hongjuan Jin, Wenwen Jian, Qing Yu, Shuli Yang	2019	10
19	Dietary β-hydroxybutyric acid improves the growth performance of young ruminants based on rumen microbiota and volatile fatty acid biosynthesis Frontiers in Microbiology ·Jianmin Chai, Zeyue Liu, Jun Wu, Yuan Kang, Mahmoud M. Abdelsattar, Wei Zhao, Shiqin Wang, Shuli Yang, Feilong Deng, Ying Li, Yimin Zhuang, Naifeng Zhang	2024	9
20	MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT Archives of Medical Science ·Min Wei, Hongjuan Jin, Shuli Yang, Zhuo Li, Xinlei Wang, Lixiang Li, Yan Jia, Manhua Cui	2019	9

About Shuli Yang

Shuli Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 34 papers that have together received 616 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (5 papers), Endometriosis Research and Treatment (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (162 citations), Obstetrics and Gynecology (48 citations), Pharmacology (51 citations), Oncology (129 citations) and Immunology (99 citations). Shuli Yang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Ruixin Lin, Lihui Si, Ruiqi Yang, Yan Jia, Jiacheng Wu, Zongbing You, Keshab R. Parajuli, Shuang Liu, Leann Myers and Ting Li. Their work appears in journals such as Bioscience Reports, Frontiers in Endocrinology, Microbial Pathogenesis, European Journal of Medicinal Chemistry and Journal of Microbiology Immunology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact